Investigation of the piroxicam/hydroxypropyl-β-cyclodextrin inclusion complexation by means of a supercritical solvent in the presence of auxiliary agents

2011 ◽  
Vol 57 (3) ◽  
pp. 259-266 ◽  
Author(s):  
Mauro Banchero ◽  
Luigi Manna
2013 ◽  
Vol 579 (1) ◽  
pp. 22-29 ◽  
Author(s):  
Shigeaki Abe ◽  
Takashi Hirota ◽  
Takayuki Kiba ◽  
Naoyuki Miyakawa ◽  
Fumio Watari ◽  
...  

2019 ◽  
Vol 19 (25) ◽  
pp. 2357-2370 ◽  
Author(s):  
Mino R. Caira

Owing to their wide structural diversity and unique complexing properties, cyclodextrins (CDs) find manifold applications in drug discovery and development. The focus of this mini-review is on their uses as ‘enabling excipients’ both in the context of early drug discovery and in subsequent optimisation of drug performance. Features highlighted here include descriptions of the structures of CDs, synthetic derivatisation to fine-tune their properties, the nature of inclusion complexation of drugs within the CD cavity, methodology for the study of free and complexed hosts in the solid state and in solution, the inherent pharmacological activity of several CDs and its utility, novel CD-based drug delivery systems, and the role of CDs in drug discovery and optimisation. Illustrative examples are generally based on research reported during the last two decades. Application of CDs to the optimisation of the performance of established drugs is commonplace, but there are many opportunities for the intervention of CDs during the early stages of drug discovery, which could guide the selection of suitable candidates for development, thereby contributing to reducing the attrition rate of new molecular entities.


2011 ◽  
Vol 40 (2) ◽  
pp. 327-347 ◽  
Author(s):  
J. Premakumari ◽  
G. Allan Gnana Roy ◽  
A. Antony Muthu Prabhu ◽  
G. Venkatesh ◽  
V. K. Subramanian ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document